- Description
- Specifications
Catalog #: IHA-003
Description:
Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/ New Caledonia/20/99 IVR 116. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.
Purity:
Greater than 90.0% as determined byAnalysis by SDS-PAGE.
Formulation:
The H1N1 A/New Caledonia/20/99 IVR solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal.
Stability:
A/New Caledonia/20/99 IVR although stable 4 °C for 4 weeks, should be stored desiccated below -18 °C.
Please prevent freeze-thaw cycles.
Activity:
Tested with anti-influenza A monoclonal antibodies in ELISA.Serological studies of influenza A virus, immunogen for antibody production.
Physical Appearance:
Sterile Filtered colorless solution.
Inactivation:
Thimerosal and beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
References:
Title:A Patented Strain of Bacillus coagulans Increased Immune Response to Viral Challenge .
Publication:DOI: 10.3810/pgm.2009.03.1971 Postgraduate Medicine: Volume: 121 No.2
Link:http://postgradmed.org/doi/10.3810/pgm.2009.03.1971
